Home › Angelman Syndrome › Illinois
Angelman Syndrome clinical trials in Illinois
3 studies for Angelman Syndrome are looking for participants at sites in Illinois.
Cities in Illinois
BEACON - Phase III Clinical Study of Rugonersen in Angelman Syndrome.
- Rush University, Chicago
RecruitingPhase 3
Ages 1 to 50 · All sexes · Updated Sep 10, 2026 · NCT07605429A Phase 1/2 Study of the Safety and Efficacy of MVX-220 in Angelman Syndrome
- Rush University Medical Center, Chicago
RecruitingPhase 1/2
Ages 4 to 50 · All sexes · Updated Jul 24, 2026 · NCT07181837Angelman Syndrome Natural History Study
- Rush University Children's Hospital, Chicago
RecruitingObservational study
All ages · All sexes · Updated Apr 3, 2025 · NCT04507997From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.